April 25th 2024
PharmaLinea to introduce a new, clinically studied product for the support of joint pain and mobility, as well as line extensions to its >Your< Prediabetiq and >Your< Iron product lines.
Role of vitamin K2 on cardiovascular health subject of presentation at nephrology symposium
January 6th 2023Central to the discussion was a new study that is investigating the effects of 1 mg of MenaQ7 Vitamin K2 as MK-7 from Gnosis by Lesaffre versus placebo on arterial stiffness and the occurrence of cardiovascular events in end-stage renal disease patients undergoing peritoneal dialysis over the course of 1.5 years.